Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

Holders of 5% or more of CBAY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CymaBay Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of CymaBay Therapeutics, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

23 Schedule 13D and 13G filings on CymaBay Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CBAY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2024Commodore Capital LP13G/AOld format–––SEC
Feb 14, 2024Janus Henderson Group PLC13GOld format–New–SEC
Feb 14, 2024Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2024Avoro Capital Advisors LLC13G/AOld format–––SEC
Feb 13, 2024TCG Crossover GP I, LLC13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13GOld format–––SEC
Jan 25, 20241:48 PM ETBlackRock Inc.13GOld format–––SEC
Sep 22, 2023Ra Capital Management, L.P.13GOld format–New–SEC
Sep 11, 2023Adage Capital Partners GP, L.L.C.13GOld format–New–SEC
Mar 10, 2023Perceptive Advisors LLC13GOld format–New–SEC
Feb 14, 2023Commodore Capital LP13G/AOld format–––SEC
Feb 14, 2023TCG Crossover GP I, LLC13G/AOld format–––SEC
Jul 8, 20224:57 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2022Boxer Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Commodore Capital LP13G/AOld format–––SEC
Feb 11, 2022Avoro Capital Advisors LLC13G/AOld format–––SEC
Feb 1, 20225:08 PM ETBlackRock Inc.13G/AOld format–––SEC
Nov 29, 2021TCG Crossover Management, LLC13GOld format–New–SEC
Jul 12, 2021Commodore Capital LP13GOld format–New–SEC
Feb 16, 2021D. E. Shaw & Co, L.P.13G/AOld format–––SEC
Feb 16, 2021Foresite Capital Fund III, L.P.13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Jan 29, 20219:57 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

45 notices from officers, directors and other affiliates planning to sell CymaBay Therapeutics, Inc. shares, newest first.

Form 144 notices for CBAY
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Feb 15, 20244:15 PM ETDaniel MenoldOfficer10.0K$321.8KFeb 15, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 12, 20244:06 PM ETJanet DorlingDirector6.00K$191.8KFeb 12, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 6, 20245:38 PM ETStuart Lewis JOfficer30.6K$733.3KFeb 6, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Feb 1, 20245:00 PM ETMenold DanielOfficer25.0K$600.0KFeb 1, 2024MORGAN STANLEY SMITH BARNEY LLC, EXECUTIVE SERVICESSEC
Jan 30, 20246:33 PM ETMenold DanielOfficer25.0K$593.8KJan 30, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 29, 20245:59 PM ETMenold DanielOfficer50.0K$1.20MJan 29, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 26, 20245:21 PM ETMenold DanielOfficer20.0K$460.8KJan 26, 2024MORGAN STANLEY SMITH BARNEY LLC, EXECUTIVE SERVICESSEC
Jan 22, 20244:33 PM ETStuart Lewis JOfficer62.3K$1.53MJan 22, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 19, 20247:15 PM ETCharles McWherterOfficer18.4K$435.6KJan 19, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 19, 20244:44 PM ETStuart Lewis JOfficer50.0K$1.17MJan 19, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 18, 20244:39 PM ETStuart Lewis JOfficer60.7K$1.42MJan 18, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 17, 20244:54 PM ETStuart Lewis JOfficer40.2K$939.7KJan 17, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Jan 16, 20244:24 PM ETPaul QuinlanOfficer5.00K$117.9KJan 16, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 16, 20244:23 PM ETDaniel MenoldOfficer10.0K$235.8KJan 16, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 10, 20244:11 PM ETJanet DorlingDirector6.00K$143.1KJan 10, 202410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 3, 20244:50 PM ETStuart Lewis JOfficer337.6K$8.19MJan 3, 2024Morgan Stanley Smith Barney LLC Executive ServicesSEC
Dec 18, 20234:07 PM ETCharles McWherterOfficer11.3K$243.4KDec 18, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 15, 20234:22 PM ETPaul QuinlanOfficer5.00K$109.9KDec 15, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 15, 20234:21 PM ETDaniel MenoldOfficer21.5K$472.6KDec 15, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 11, 20234:39 PM ETSujal A ShahOfficer · Director64.9K$1.30MDec 11, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 11, 20234:16 PM ETJanet DorlingDirector6.00K$120.4KDec 11, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 17, 20234:07 PM ETCharles McWherterOfficer11.3K$207.3KNov 17, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 15, 20234:14 PM ETPaul QuinlanOfficer5.00K$86.9KNov 15, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 15, 20234:13 PM ETDaniel MenoldOfficer17.5K$304.1KNov 15, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 13, 20234:22 PM ETSujal A ShahOfficer · Director64.9K$1.03MNov 13, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC

Showing the latest 25. See the CBAY notices from the last 12 months